HRSA, In Bid To Delay 340B Rule, Says Drug-Price Plan To Span Medicare, Medicaid, 340B

May 09, 2018
The Health Resources and Services Administration proposed to again delay implementing the 340B ceiling price and penalty rule, and in the process revealed the Trump administration's highly anticipated plan to stem drug costs likely will affect four government health programs: 340B, Medicare Parts B and D, and Medicaid. HRSA says it wouldn't make sense to put the 340B rule into place when a broad HHS drug-cost containment plan will also deal with the program. The agency made the statement Friday...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.